Drug-Induced Lupus is Rare with TNF inhibitor Therapy
Drug-induced lupus (DIL) has been associated with all TNF inhibitors. Early rates suggested this may be between 0.04 - 0.06 events per 100 patient-years or roughtly 5 per 1000 patient-years.
Hot Stuff from the Cleveland Clinic Biologic Therapies Summit – Part I
Under the direction of Dr. Len Calabrese, the Cleveland Clinic Center for Continuing Education hosted its 6th biennial Biologic Therapies Summit this week (April 30 – May 2, 2015). Below are highlights and take-home messages from several presentations at this conference.
A different point of view on RA
Professor Fergus Shanahan, a consultant gastroenterologist and professor of medicine at University College Cork, has an issue with the label “auto-immune” disease being applied to conditions such as RA, lupus, multiple sclerosis, Crohn’s disease, asthma and type 1 diabetes.
